RGTI Vs QBTS Vs INFQ Vs IONQ: Which Quantum Computing Stock Is Retail Most Bullish On?

The Trump administration approved $2.013 billion in federal incentives under the CHIPS and Science Act for nine U.S. quantum computing companies, with IBM receiving $1 billion as the largest beneficiary. The news sparked sharp retail enthusiasm: RGTI, QBTS, and INFQ all closed up more than 30%, while IONQ gained over 12%. A Stocktwits poll showed IONQ as the most bullish retail pick at 30%, followed by QBTS at 25%, RGTI at 23%, and INFQ at 22%.

Analysis

This is less a pure sentiment event than a government-backed capital-allocation shock that re-ranks the group by survivability, not just narrative momentum. IBM is the clearest medium-term winner because subsidy dollars can be translated into manufacturing capacity, procurement lock-in, and an ecosystem moat; that tends to create follow-on enterprise demand and vendor concentration over 12-24 months. The more levered, pre-profit names can still outperform on reflexive flow, but their value capture is mostly in the first leg of the move unless the funding converts into repeat contracts or milestone-based awards.

The biggest second-order effect is that the market may start discounting quantum like a defense-adjacent industrial platform rather than a pure R&D basket. That benefits incumbents with balance-sheet credibility and hurts smaller names that need continuous equity issuance to fund burn, because cheaper competitors now have a political halo plus a funding runway. If this becomes a template for future federal support, expect supplier tightness around cryogenics, control electronics, and specialized fabrication equipment, which could compress margins for the hardware chain while widening valuation dispersion among the stocks themselves.

Near term, the risk is a classic “headline-to-delivery” gap: the stocks can stay bid for days, but any sign that awards are staged, conditional, or slow to reach revenue will deflate multiples quickly. IONQ’s comparatively weaker retail enthusiasm versus its stronger strategic positioning suggests the market is not yet fully pricing in quality of funding durability; that creates a relative-value opportunity versus the more crowded high-beta names. The contrarian read is that the move may already be over-owned in the names most exposed to momentum funds, while IBM is underappreciated because it lacks the lottery-ticket profile retail prefers.

Key Decisions for Investors

• Long IBM vs short QBTS in a 1-3 month pair: express the view that subsidy-backed moat expansion is more durable than reflexive retail beta; target 15-20% relative outperformance with a stop if QBTS retains >30% of its post-event gain for two consecutive weeks.
• Buy IONQ on a pullback over the next 5-10 trading sessions: use it as the highest-quality liquid exposure if the market rotates from meme momentum to policy durability; upside/risk is better than chasing the most extended names.
• Sell upside calls or put spreads on RGTI and QBTS into strength for a 30-60 day horizon: the risk/reward favors monetizing inflated implied volatility after the policy catalyst rather than assuming linear continuation.
• Long IBM outright on a 6-12 month horizon: treat it as the closest thing to a quantum infrastructure proxy with lower execution risk; the trade works if federal support drives enterprise follow-on demand and analyst revisions.
• Avoid initiating new outright longs in the smallest, most retail-owned names until the next funding/milestone confirmation: the key risk is a fast drawdown once the market shifts from announcement to implementation.